High turnover of tissue factor enables efficient intracellular delivery of antibody-drug conjugates

Molecular Cancer Therapeutics
Bart E C G de GoeijPaul W H I Parren

Abstract

Antibody-drug conjugates (ADC) are emerging as powerful cancer treatments that combine antibody-mediated tumor targeting with the potent cytotoxic activity of toxins. We recently reported the development of a novel ADC that delivers the cytotoxic payload monomethyl auristatin E (MMAE) to tumor cells expressing tissue factor (TF). By carefully selecting a TF-specific antibody that interferes with TF:FVIIa-dependent intracellular signaling, but not with the procoagulant activity of TF, an ADC was developed (TF-011-MMAE/HuMax-TF-ADC) that efficiently kills tumor cells, with an acceptable toxicology profile. To gain more insight in the efficacy of TF-directed ADC treatment, we compared the internalization characteristics and intracellular routing of TF with the EGFR and HER2. Both in absence and presence of antibody, TF demonstrated more efficient internalization, lysosomal targeting, and degradation than EGFR and HER2. By conjugating TF, EGFR, and HER2-specific antibodies with duostatin-3, a toxin that induces potent cytotoxicity upon antibody-mediated internalization but lacks the ability to induce bystander killing, we were able to compare cytotoxicity of ADCs with different tumor specificities. TF-ADC demonstrated effective kil...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B M MuellerW Ruf
Jan 1, 1996·Annual Review of Cell and Developmental Biology·I Mellman
Jan 30, 2003·The EMBO Journal·Josiane RagimbeauSandra Pellegrini
Nov 19, 2003·Molecular and Cellular Biochemistry·L Vijaya Mohan Rao, Usha R Pendurthi
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wim K BleekerPaul W H I Parren
Jul 22, 2005·The Journal of Biological Chemistry·Young Ho KohGiuseppina Tesco
Aug 24, 2005·Virology Journal·Martin J VincentStuart T Nichol
Feb 24, 2006·Blood·Samir K MandalL Vijaya Mohan Rao
May 13, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sherry H-Y WeiAlice L-F Mui
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alok A KhoranaMark B Taubman
Dec 7, 2007·International Journal of Cancer. Journal International Du Cancer·Geneviève PatryLouis Lacombe
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Raj S KasthuriNigel Mackman
Jul 21, 2010·Current Opinion in Chemical Biology·Stephen C AlleyPeter D Senter
Apr 22, 2011·Expert Opinion on Biological Therapy·Howard A Burris
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patricia M LoRussoMark X Sliwkowski
Oct 2, 2012·The New England Journal of Medicine·Sunil VermaUNKNOWN EMILIA Study Group
Dec 21, 2012·Chemical Biology & Drug Design·John A FlygarePaul Aristoff
Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aran F LabrijnPaul W H I Parren

❮ Previous
Next ❯

Citations

Mar 11, 2016·Current Opinion in Immunology·Bart Ecg de Goeij, John M Lambert
Mar 30, 2017·Marine Drugs·David J Newman, Gordon M Cragg
Nov 10, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Penelope M Drake, David Rabuka
Feb 24, 2018·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Osamu Kusano-AraiTakao Hamakubo
Nov 28, 2018·Journal of Cellular Physiology·Meghdad Abdollahpour-AlitappehNader Bagheri
May 29, 2020·Expert Opinion on Biological Therapy·Corinne A Calo, David M O'Malley
Nov 1, 2015·Journal of Biomolecular Screening·Thilo RiedlArnout F Gerritsen
Sep 19, 2018·Human Antibodies·Anubhab MukherjeeVenkata Mahidhar Yenugonda
Mar 18, 2017·Nature Reviews. Drug Discovery·Alain BeckNathalie Corvaïa
Jul 16, 2020·Journal of Hematology & Oncology·Dusten Unruh, Craig Horbinski
Aug 22, 2018·Molecular Cancer Therapeutics·Jan-Willem TheunissenThi-Sau Migone
Nov 4, 2016·Molecular Cancer Therapeutics·Bart E C G de GoeijPaul W H I Parren
Dec 5, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S HongRobert L Coleman
Feb 10, 2021·Nature Reviews. Clinical Oncology·Joshua Z DragoSarat Chandarlapaty
Mar 26, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Carsten H NielsenAndreas Kjaer
Nov 9, 2021·Drugs·Anthony Markham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.